(AIZN) Assurant - Ratings and Ratios

Exchange: NYSE • Country: USA • Currency: USD • Type: Common Stock • ISIN: US04621X3061

AIZN: Life, Property, Casualty, Specialty Insurance

Assurant Inc (NYSE:AIZN) operates as a leading global provider of lifestyle and housing solutions, specializing in insurance products and services. The company focuses on areas such as mobile devices, appliances, and other consumer electronics, as well as mortgage and property solutions. AIZN is listed on the New York Stock Exchange (NYSE) and is classified under the Multi-line Insurance sub-industry within the broader financial services sector. The company is headquartered in the United States and serves a diverse customer base across multiple regions.

From a technical perspective, AIZN is currently trading at $19.20, slightly below its 20-day simple moving average (SMA) of $19.64. The 50-day SMA stands at $20.17, while the 200-day SMA is at $20.93, indicating a recent downtrend. The average true range (ATR) of 0.33 reflects relatively low price volatility, suggesting stability in recent trading activity. The average 20-day volume is 15,350 shares, indicating moderate liquidity in the stock.

On the fundamental side, AIZN has a market capitalization of $9,377.53 million, categorizing it as a large-cap company. The return on equity (RoE) is 14.89%, highlighting strong profitability from shareholders equity. However, the price-to-earnings (P/E) ratio is currently 0.00, likely due to negative earnings in the most recent fiscal year. The forward P/E ratio is also 0.00, reflecting expectations of continued earnings challenges. Other valuation metrics such as P/B and P/S are not available, limiting a comprehensive fundamental analysis.

3-Month Forecast: Based on the provided data, AIZN is expected to remain range-bound between $18.80 and $20.50 over the next three months. The stock may face resistance near the 200-day SMA of $20.93, while support is likely to hold around the 20-day SMA of $19.64. The low ATR of 0.33 suggests minimal price fluctuations, with potential for a slight upward drift if the stock breaks above the 50-day SMA of $20.17. Fundamental factors, such as improving profitability or positive earnings surprises, could drive upside momentum, while macroeconomic headwinds may weigh on performance.

Additional Sources for AIZN Stock

AIZN Stock Overview

Market Cap in USD 9,378m
GiC Sub-Industry Multi-line Insurance
IPO / Inception 2020-11-25

AIZN Stock Ratings

Growth Rating -13.6
Fundamental 76.4
Dividend Rating 35.4
Rel. Strength -17.3
Analysts -
Fair Price Momentum 18.68 USD
Fair Price DCF -

AIZN Dividends

Dividend Yield 12m 4.98%
Yield on Cost 5y 4.75%
Annual Growth 5y -3.55%
Payout Consistency 94.4%

AIZN Growth Ratios

Growth Correlation 3m -86.1%
Growth Correlation 12m -10.3%
Growth Correlation 5y -18%
CAGR 5y -1.64%
CAGR/Max DD 5y -0.06
Sharpe Ratio 12m 0.50
Alpha -6.61
Beta 0.300
Volatility 18.99%
Current Volume 7.9k
Average Volume 20d 23.7k
What is the price of AIZN stocks?
As of April 19, 2025, the stock is trading at USD 19.27 with a total of 7,900 shares traded.
Over the past week, the price has changed by +0.94%, over one month by -1.04%, over three months by -5.47% and over the past year by -1.65%.
Is Assurant a good stock to buy?
Yes, based on ValueRay Fundamental Analyses, Assurant (NYSE:AIZN) is currently (April 2025) a good stock to buy. It has a ValueRay Fundamental Rating of 76.44 and therefor a positive outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of AIZN as of April 2025 is 18.68. This means that AIZN is currently overvalued and has a potential downside of -3.06%.
Is AIZN a buy, sell or hold?
Assurant has no consensus analysts rating.
What are the forecast for AIZN stock price target?
According to ValueRays Forecast Model, AIZN Assurant will be worth about 20.2 in April 2026. The stock is currently trading at 19.27. This means that the stock has a potential upside of +4.67%.
Issuer Forecast Upside
Wallstreet Target Price - -
Analysts Target Price - -
ValueRay Target Price 20.2 4.7%